Scinai Immunotherapeutics (SCNI) Investment Income (2023 - 2024)
Scinai Immunotherapeutics' (SCNI) quarterly Investment Income came in at $10.5 million in Q3 2024, up 436.5% year-on-year from $1.9 million in Q4 2023, and up 436.5% quarter-over-quarter from -$3.1 million in Q3 2023.
Scinai Immunotherapeutics (SCNI) Investment Income (2023 - 2024) Analysis & Trends
Scinai Immunotherapeutics has disclosed Investment Income across 2 years of filings, most recently posting $10.5 million for Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inv. Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 3.02 Bn | 988.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 10.46 Mn |
| Sep 30, 2023 | -3.11 Mn |